{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jachs M"],"funding":["Fonds Zukunft Österreich"],"pagination":["874-884"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC12934544"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["63(6)"],"pubmed_abstract":["<h4>Background</h4>Indocyanine green (ICG) clearance, determined by venous sampling, has shown promising results in the diagnosis of clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD) and prognostication in decompensated ACLD (decompensated cirrhosis). Data on ICG clearance measurement by pulse dye densitometry (PDD) via finger clip are comparatively scarce.<h4>Aims</h4>To evaluate the diagnostic (CSPH) and prognostic utility of ICG clearance throughout ACLD stages.<h4>Methods</h4>ACLD (liver stiffness ≥ 10 kPa) patients undergoing same-day hepatic venous pressure gradient (HVPG) measurement and ICG clearance assessment via PDD in 2017-2022 were recruited from the prospective Vienna Cirrhosis Study (VICIS, NCT03267615).<h4>Results</h4>Tw"],"journal":["Alimentary pharmacology & therapeutics"],"pubmed_title":["Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death."],"pmcid":["PMC12934544"],"funding_grant_id":["LBG_KFG_22_32"],"pubmed_authors":["Semmler G","Sebesta C","Balcar L","Bauer D","Pinter M","Trauner M","Mandorfer M","Thone P","Simbrunner B","Jachs M","Kramer G","Dominik N","Stattermayer AF","Reiberger T","Carvalho T","Hartl L","Schwarz M","Hofer BS"],"additional_accession":[]},"is_claimable":false,"name":"Indocyanine Green Clearance Correlates With Biomarkers Reflecting Key Disease-Driving Mechanisms in Advanced Chronic Liver Disease and Predicts Acute-on-Chronic Liver Failure and Death.","description":"<h4>Background</h4>Indocyanine green (ICG) clearance, determined by venous sampling, has shown promising results in the diagnosis of clinically significant portal hypertension (CSPH) in compensated advanced chronic liver disease (cACLD) and prognostication in decompensated ACLD (decompensated cirrhosis). Data on ICG clearance measurement by pulse dye densitometry (PDD) via finger clip are comparatively scarce.<h4>Aims</h4>To evaluate the diagnostic (CSPH) and prognostic utility of ICG clearance throughout ACLD stages.<h4>Methods</h4>ACLD (liver stiffness ≥ 10 kPa) patients undergoing same-day hepatic venous pressure gradient (HVPG) measurement and ICG clearance assessment via PDD in 2017-2022 were recruited from the prospective Vienna Cirrhosis Study (VICIS, NCT03267615).<h4>Results</h4>Tw","dates":{"release":"2026-01-01T00:00:00Z","publication":"2026 Mar","modification":"2026-07-16T21:40:23.049Z","creation":"2026-07-10T03:15:54.762Z"},"accession":"S-EPMC12934544","cross_references":{"pubmed":["41194563"],"doi":["10.1111/apt.70447"]}}